No Detail Found!

Nodular lymphocytic predominant hodgkin lymphoma (NLPHL); treatment outcome study in a tertiary care cancer hospital in pakistan

Author(s)
Chandumal Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan,
Mohammad Iqbal Shah Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan,
Muhammad Abu Bakar Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan,
Fareeha Sheikh Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan,
Iqra Nadeem Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan,
Umme Kulsoom Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan,
Neelam Siddiqui Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan,
Abstract
Objective: To determine the demographics, clinical characteristics and treatment outcomes of nodular lymphocytic predominant Hodgkin lymphoma (NLPHL) patients treated at our hospital. Study Design: Retrospective longitudinal study. Place and Duration of Study: Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan from 1996 to 2016. Methodology: We collected clinical data of all the cases of HL diagnosed over twenty years (between 1996 and 2016) from our electronic hospital information system (HIS). A total of 3426 HL patients were identified, out of whom the pathologically confirmed diagnosis of nodular lymphocytic predominant Hodgkin lymphoma (NLPHL) was identified. Results: In this study, eighty-four patients were studied. The majority of the patients were male (80%). B symptoms were present in 35%. There were 24% patients in stage-I (n=20/84), 33% in stage-II (n=28/84), 12% in stage III (n=10/84) and 31% in stage IV (n=26/84). Hence, early-stage was seen in 57% (n=48/84) and advanced stage was 43% (n=36/84) respectively. The Median follows up time was 30 months (range: 1-60 months). Patients were treated with chemotherapy in most cases (48%), radiotherapy alone in 14% cases, and combined modality (chemotherapy and radiotherapy) was used in 38% patients. The estimated 5-year disease-free survival was 73% and overall survival was 86%. Autologous stem cell transplant was done in only one patient whose disease had transformed from NLPHL to T-rich cell B cell lymphoma. Conclusion: This study confirmed the divergent features of NLPHL with a comparatively good long-term prognosis. Most patients achieved an excellent response to first-line therapy. There was a tendency towards multiple relapses but improved outcomes.
Publication Details
Page(s) 599-603
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 72, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
B symptoms, Hodgkin Lymphoma, Shaukat khanum memorial cancer hospital and research centre lahore, Nodular lymphocytic predominant hodgkin lymphoma, First-line therapy
0

Citations

0

Downloads

79

Views